Medical device manufacturers should follow these 3 steps to commercialize products in Korea. 1) Product registration in MFDS 2) New technology assessment in NECA 3) Reimbursement assessment in HIRA. In summary, allotting 430 days are required when following those 3 steps conducted by the Korean license holder(if no affiliate in Korea, one should appoint a license holder)